[go: up one dir, main page]

ES8308698A1 - Procedimiento para preparar una composicion penetrable por la piel a base de agentes terapeuticos sistematicamente activos - Google Patents

Procedimiento para preparar una composicion penetrable por la piel a base de agentes terapeuticos sistematicamente activos

Info

Publication number
ES8308698A1
ES8308698A1 ES511169A ES511169A ES8308698A1 ES 8308698 A1 ES8308698 A1 ES 8308698A1 ES 511169 A ES511169 A ES 511169A ES 511169 A ES511169 A ES 511169A ES 8308698 A1 ES8308698 A1 ES 8308698A1
Authority
ES
Spain
Prior art keywords
therapeutic agents
composition
penetrable
active therapeutic
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES511169A
Other languages
English (en)
Other versions
ES511169A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH2327/81A external-priority patent/CH653256A5/de
Priority claimed from CH2631/81A external-priority patent/CH647149A5/de
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES8308698A1 publication Critical patent/ES8308698A1/es
Publication of ES511169A0 publication Critical patent/ES511169A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

COMPOSICION PENETRANTE POR LA PIEL A BASE DE AGENTES TERAPEUTICOS SISTEMATICAMENTE ACTIVOS Y DE DIFICIL PENETRACION. ADEMAS DEL AGENTE FARMACOLOGICAMENTE ACTIVO QUE PUEDE SER DIFICILMENTE PENETRABLE EN LA PIEL, SE INCLUYEN EXCIPIENTES COMPATIBLES CON ESTA CAPACES DE FUNCIONAR COMO DISOLVENTES ORGANICOS INMISCIBLES EN AGUA, UN EMULSIONANTE Y UN CO-EMULSIONANTE. LOS INGREDIENTES SE CALIENTAN DE 60 A 95 C, SIN PASAR DE 100 C, ENFRIANDO POSTERIORMENTE HASTA 15 O 35 C PARA FORMAR UNA MICROEMULSION.
ES511169A 1981-04-06 1982-04-05 Procedimiento para preparar una composicion penetrable por la piel a base de agentes terapeuticos sistematicamente activos Granted ES511169A0 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH2327/81A CH653256A5 (en) 1981-04-06 1981-04-06 Microemulsion for cutaneous use
CH2631/81A CH647149A5 (en) 1981-04-22 1981-04-22 Composition with 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole for cutaneous use
CH327881 1981-05-20

Publications (2)

Publication Number Publication Date
ES8308698A1 true ES8308698A1 (es) 1983-10-01
ES511169A0 ES511169A0 (es) 1983-10-01

Family

ID=27173625

Family Applications (1)

Application Number Title Priority Date Filing Date
ES511169A Granted ES511169A0 (es) 1981-04-06 1982-04-05 Procedimiento para preparar una composicion penetrable por la piel a base de agentes terapeuticos sistematicamente activos

Country Status (16)

Country Link
AU (1) AU564570B2 (es)
CA (1) CA1192496A (es)
DE (1) DE3212053A1 (es)
DK (1) DK155882A (es)
ES (1) ES511169A0 (es)
FI (1) FI821123L (es)
FR (1) FR2502951B1 (es)
GB (2) GB2098865B (es)
GR (1) GR75462B (es)
IL (1) IL65424A0 (es)
IT (1) IT8220611A0 (es)
MY (1) MY8600571A (es)
NL (1) NL8201413A (es)
NZ (1) NZ200232A (es)
PT (1) PT74703B (es)
SE (1) SE8202172L (es)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655656B (es) * 1982-10-07 1986-05-15
CA1225594A (en) * 1983-05-20 1987-08-18 Jourge Heller Method for percutaneously administering physiologically active agents
DE3406497A1 (de) * 1984-02-23 1985-09-05 Mueller Bernhard Willi Werner Hochdisperse pharmazeutische mehrkomponentensysteme und verfahren zu ihrer herstellung
US5364628A (en) * 1985-05-31 1994-11-15 Sandoz Ltd. Pharmaceutical compositions
JPH0667835B2 (ja) * 1984-03-01 1994-08-31 サンド・アクチエンゲゼルシヤフト 医薬組成物
US5639724A (en) 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
JPS61280426A (ja) * 1985-06-04 1986-12-11 Ikeda Mohandou:Kk 消炎鎮痛用貼付剤
US4767625A (en) * 1985-09-02 1988-08-30 Kao Corporation Lamella type single phase liquid crystal composition and oil-base cosmetic compositions using the same
US4690774A (en) 1985-09-11 1987-09-01 Chesebrough Pond's Inc. Novel translucent water in oil emulsions
US4797272A (en) * 1985-11-15 1989-01-10 Eli Lilly And Company Water-in-oil microemulsions for cosmetic uses
DE3805744C2 (de) * 1987-03-04 1999-09-23 Novartis Ag Phenylcarbamate zur Hemmung der Acetylcholinesterase
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US7081445B2 (en) 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
DE3908047A1 (de) * 1989-03-13 1990-09-20 Desitin Arzneimittel Gmbh Hochdisperse pharmazeutische zusammensetzung
US5324521A (en) * 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments
US5149719A (en) * 1990-04-27 1992-09-22 Minnesota Mining And Manufacturing Company Composition for transdermal penetration of medicaments
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
JPH06507172A (ja) * 1991-04-19 1994-08-11 アフィニティー　バイオテック，インコーポレイテッド 転換可能なミクロエマルジョン処方剤
US6005001A (en) * 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
GB9111611D0 (en) 1991-05-30 1991-07-24 Sandoz Ltd Liposomes
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
GB9126209D0 (en) * 1991-12-10 1992-02-12 Orion Yhtymae Oy Drug formulations for parenteral use
MX9207344A (es) * 1991-12-16 1993-07-01 Alza Corp Formulaciones mejoradas que tienen mejoradores hidrofobicos de penetracion transdermica y metodo para proveerla.
US5629019A (en) * 1992-02-27 1997-05-13 Alza Corporation Formulations with hydrophobic permeation enhancers
ES2098739T3 (es) 1992-05-13 1997-05-01 Sandoz Ltd Composiciones oftalmicas conteniendo una cyclosporin.
ES2168271T3 (es) 1992-09-25 2002-06-16 Novartis Ag Composiciones farmaceuticas que contienen ciclosporinas.
WO1994008610A1 (en) * 1992-10-16 1994-04-28 Smithkline Beecham Corporation Pharmaceutical emulsion compositions
JPH08507065A (ja) * 1993-02-17 1996-07-30 スミスクライン・ビーチャム・コーポレイション 医薬組成物含有のミクロエマルジョン
JP3833248B2 (ja) 1994-11-03 2006-10-11 ノバルティス・アクチエンゲゼルシャフト 簡単な組成及び高い生物有効性を有する経口投与のためのシクロスポリンの新規処方物及びその製造法
DE4442999A1 (de) * 1994-12-02 1996-06-05 Hexal Pharma Gmbh Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten
DE19549852B4 (de) 1995-11-29 2009-06-04 Novartis Ag Cyclosporin enthaltende Präparate
US5958876A (en) * 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
AU737053B2 (en) 1997-01-30 2001-08-09 Novartis Ag Oil-free pharmaceutical compositions containing cyclosporin A
IN188719B (es) * 1997-09-08 2002-11-02 Panacea Biotec Ltd
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
UY25225A1 (es) 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
US6391282B1 (en) * 1997-11-10 2002-05-21 Flemington Pharmaceutical Corp. Antihistamine sprays and ointments for relief of delayed contact dermatitis
DE19825856A1 (de) * 1998-06-10 1999-12-16 Labtec Gmbh Topische Arzneimittelzubereitung
IL143580A0 (en) * 1998-12-11 2002-04-21 Pharmasolutions Inc Pharmaceutical compositions containing lipophilic drugs and methods for the preparation thereof
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
EP1644004A4 (en) * 2003-06-20 2010-10-06 Ronald Aung-Din LOCAL THERAPY FOR THE TREATMENT OF MIGRAINS, MUSCLE CLARIFICATIONS, MUSCLE SPASMS, SPASTICITY AND RELATED CONDITIONS
AU2004296784B2 (en) 2003-12-08 2010-12-02 Cpex Pharmaceuticals, Inc. Pharmaceutical compositions and methods for insulin treatment
US20060078580A1 (en) 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US7740875B2 (en) 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US9308203B2 (en) * 2008-10-01 2016-04-12 Taiwan Biotech Co., Ltd. Pressure sensitive adhesive matrix device or system for the treatment or prevention of onychomycosis or tinea pedis
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
CA3020153A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
CA3078723A1 (en) 2016-11-28 2018-05-31 Nachiappan Chidambaram Oral testosterone undecanoate therapy
US12150945B2 (en) 2018-07-20 2024-11-26 Lipocine Inc. Liver disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH570401A5 (es) * 1972-05-09 1975-12-15 Wander Ag Dr A
GB1559811A (en) * 1975-07-28 1980-01-30 Sandoz Ltd Pharmaceutically active benzothiadiazole derivatives
CH632268A5 (de) * 1977-01-14 1982-09-30 Sandoz Ag Verfahren zur herstellung von neuen heterocyclylaminoderivaten.

Also Published As

Publication number Publication date
GR75462B (es) 1984-07-20
FI821123A7 (fi) 1982-10-07
GB2098865B (en) 1985-12-18
FR2502951B1 (fr) 1985-12-06
GB2148711A (en) 1985-06-05
ES511169A0 (es) 1983-10-01
FI821123A0 (fi) 1982-03-31
PT74703A (en) 1982-05-01
DK155882A (da) 1982-12-10
IT8220611A0 (it) 1982-04-06
GB2148711B (en) 1985-12-18
MY8600571A (en) 1986-12-31
AU564570B2 (en) 1987-08-20
PT74703B (en) 1984-05-30
GB2098865A (en) 1982-12-01
SE8202172L (sv) 1982-10-07
FI821123L (fi) 1982-10-07
AU8233482A (en) 1982-10-14
NZ200232A (en) 1985-08-16
FR2502951A1 (fr) 1982-10-08
DE3212053A1 (de) 1982-10-21
CA1192496A (en) 1985-08-27
NL8201413A (nl) 1982-11-01
GB8408654D0 (en) 1984-05-16
IL65424A0 (en) 1982-07-30

Similar Documents

Publication Publication Date Title
ES8308698A1 (es) Procedimiento para preparar una composicion penetrable por la piel a base de agentes terapeuticos sistematicamente activos
ES2155931T3 (es) Forma de administracion de un agente activo de liberacion prolongada en banda.
EP0069385A3 (en) Use of eucalyptol for enhancing skin permeation of bioaffecting agents
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
ES2099094T3 (es) Metodos y composiciones para tratamiento de interacciones hidrofobas patologicas en fluidos biologicos.
BG101278A (bg) Твърди системи за контролирано освобождаване и методи за получаването им
MY102859A (en) A composition for the control of insects.
ES2071306T3 (es) El uso de tensioactivos fluorados solubles para la preparacion de formulaciones aerosoles dosificadas.
ES2090131T3 (es) Solucion antineoplasica y procedimiento para el tratamiento de neoplasmas.
ES2190472T3 (es) Parche transdermico para la administracion de 17-deacetil norgestimato, solo o en combinacion con un estrogeno.
BR9913154A (pt) Composição de musse
DK1299108T3 (da) Parasiticidt præparat samt fremgangsmåde til fremstilling af dette præparat
DK0759747T3 (da) Transdermal indretning til administration gennem de-epitheliseret hud
ES2167061T3 (es) Formas de dosificacion para mejorar la disfuncion erectil en pacientes de sexo masculino.
MXPA01003182A (es) Sistema de liberacion controlada de agentes antifungicos y queratoliticos para el tratamiento local de las infecciones fungicas de la una y los tejidos circundantes.
PT93191A (pt) Sistema terapeutico para a administracao retardada e controlada transdermica ou transmucosica de substancias activas
ES2051733T3 (es) Procedimiento de obtencion de un medicamento a base de tamoxifen para uso local.
ES2052745T3 (es) Formulaciones farmaceuticas que contienen melfalan o hidrocloruro de melfalan, asi como melfalan e hidrocloruro de melfalan y procedimientos para prepararlas.
SE8803221L (sv) Vattenloesliga monoestrar som solubiliseringsmedel foer farmakologiskt aktiva foereningar och farmaceutiska excipienter
DE3587794D1 (de) Pharmazeutische Präparate.
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
AR246159A1 (es) Agente antiparasitario con accion mejorada.
NO153495C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive morfantridin-derivater.
SE8101374L (sv) Kompositioner innehallande n,n-dietyl-m-toluamid
GT200000224A (es) Composicion para el tratamiento de tejidos dañados.